12011-3 |
Replicate summarization |
Type |
Measurement |
Pt |
* |
|
|
ACTIVE |
Replicate summarization |
|
MIN |
DefinitionDescription |
|
|
|
Each replicate reported, Mean of all replicates reported, Mean of selected replicates reported, Maximum of replicates reported, Minimum of replicates reported, Modal replicate reported, Management of replicates not specified. |
|
|
|
|
|
OB.US |
|
12011-3 |
|
|
|
|
Observation |
|
|
|
0 |
Replicate sum |
|
|
|
Y |
|
OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Point in time; Random; Summary; Typ |
2.29 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |
|
95149-1 |
Hepatitis B virus surface Ag panel |
- |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Hepatitis B virus surface Ag panel - Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
95149-1 |
|
|
|
|
Order |
|
|
|
0 |
HBV surface Ag Pnl SerPl |
|
|
|
|
|
Australia antigen; HBs; HBsAG; HBV; HBV surface; HBV surface Ag Pnl; Hep; Hep B; Hep Bs; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Liver; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Surf |
2.68 |
2.68 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|
95361-2 |
U.S. Household Food Security Survey - Six-Item Short Form |
- |
^Patient |
12Mo |
- |
U.S. Food Security Survey |
|
ACTIVE |
U.S. Household Food Security Survey - Six-Item Short Form [U.S. FSS] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.SDOH |
|
95361-2 |
|
U.S. Food Security Survey |
|
|
Both |
|
|
|
0 |
|
|
|
|
|
|
1 year; 12Mos; Pan; Panel; Panl; Pnl; S prime; SDOH |
2.69 |
2.68 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|
101172-5 |
Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis rRNA panel |
- |
XXX |
Pt |
- |
Probe.amp.tar |
|
ACTIVE |
Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis rRNA panel - Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
101172-5 |
|
Probe.amp.tar |
|
|
Order |
|
|
|
0 |
CT + NG + TV rRNA Pnl Spec NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C trac; C trach; C trach+GC; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; CT + NG + TV; CT + NG + TV rRNA Pnl; CT/GC; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gen-Probe; Gono; Gonorrhea; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; Misc; Miscellaneous; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; ribosomal RNA; SDA; Spec; Strand Displacement Amplification; T vaginalis; TMA; To be specified in another part of the message; Trachoma; Transcription mediated amplification; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis; Unspecified |
2.75 |
2.74 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|
94537-8 |
Hemoglobin panel |
- |
Bld |
Pt |
- |
HPLC |
|
ACTIVE |
Hemoglobin panel - Blood by HPLC |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEM/BC |
|
94537-8 |
|
HPLC |
|
|
Order |
|
|
|
0 |
Hgb Pnl Bld HPLC |
|
|
|
|
|
Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb Pnl; High performance liquid chromatography; High pressure liquid chromatography; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; Random; WB; Whole blood |
2.72 |
2.68 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|
94538-6 |
Hemoglobin HPLC & electrophoresis panel |
- |
Bld |
Pt |
- |
|
|
ACTIVE |
Hemoglobin HPLC and electrophoresis panel - Blood |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEM/BC |
|
94538-6 |
|
|
|
|
Order |
|
|
|
0 |
Hgb HPLC + electrophoresis Pnl Bld |
|
|
|
|
|
Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb HPLC + electrophoresis Pnl; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; Random; WB; Whole blood |
2.72 |
2.68 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|
94540-2 |
Mycobacterial stain & culture panel |
- |
XXX |
Pt |
- |
|
|
ACTIVE |
Mycobacterial stain and culture panel - Specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
94540-2 |
|
|
|
|
Order |
|
|
|
0 |
Mycobacterial stain + cx Pnl Spec |
|
|
|
|
|
ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Mycobacterial stain + cx Pnl; Other; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Spec; St; Stains; Stn; To be specified in another part of the message; Unspecified |
2.69 |
2.68 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|
94541-0 |
Mycobacterial identification panel |
- |
XXX |
Pt |
- |
Molgen |
|
ACTIVE |
Mycobacterial identification panel - Specimen by Molecular genetics method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
94541-0 |
|
Molgen |
|
|
Order |
|
|
|
0 |
Mycobacterial ID Pnl Spec |
|
|
|
|
|
ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Molecular genetics; Mycobacterial ID Pnl; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Random; Spec; To be specified in another part of the message; Unspecified |
2.69 |
2.68 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|
95239-0 |
Hepatitis D virus Ab.IgM panel |
- |
Ser |
Pt |
- |
|
|
ACTIVE |
Hepatitis D virus IgM panel - Serum |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
95239-0 |
|
|
|
|
Order |
|
|
|
0 |
HDV IgM Pnl Ser |
|
|
|
|
|
Delta hepatitis; Dextro; HDV; HDV IgM Pnl; HDVAB; Hep; Hep D; Hep Delta; Hepatis; Hepatit; Hepatitis delta virus; Hepatology; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Liver; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR |
2.68 |
2.68 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|
95246-5 |
U.S. Household Food Security Survey |
- |
^Patient |
12Mo |
- |
U.S. Food Security Survey |
|
ACTIVE |
U.S. Household Food Security Survey [U.S. FSS] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.SDOH |
|
95246-5 |
|
U.S. Food Security Survey |
|
|
Both |
|
|
|
0 |
|
|
|
|
|
|
1 year; 12Mos; Pan; Panel; Panl; Pnl; S prime; SDOH |
2.69 |
2.68 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|
98008-6 |
Neonatal infant pain scale panel |
- |
^Patient |
Pt |
- |
NIPS |
|
DEPRECATED |
Deprecated Neonatal infant pain scale panel |
|
DEL |
DefinitionDescription |
|
|
|
|
�© 1989, Children's Hospital of Eastern Ontario. Used with permission. |
|
|
|
|
PANEL.NEONAT |
|
98008-6 |
|
NIPS |
|
|
Order |
|
|
|
0 |
Deprecated NIPS |
|
|
|
N |
|
Pan; PANEL.NEONAT; Panl; Pnl; Point in time; Random |
2.75 |
2.7 |
|
Panel |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
COMMON_SI_TEST_RANK |
103202-8 |
SARS coronavirus 2 RNA |
- |
Respiratory |
Pt |
- |
Probe.amp.tar |
|
DEPRECATED |
Deprecated SARS-CoV-2 (COVID-19) RNA in Respiratory specimen by NAA with probe detection |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
103202-8 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Deprecated SARS-CoV-2 RNA Resp NAA+probe |
|
|
|
N |
|
2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; II; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; Panel; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SDA; Severe Acute Respiratory Syndrome; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus |
2.76 |
2.75 |
|
Panel |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
COMMON_SI_TEST_RANK |
103204-4 |
External Steroid panel |
- |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
External Steroid panel Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
103204-4 |
|
|
|
|
Order |
|
|
|
0 |
Ext steroid pnl SerPl |
|
|
|
N |
|
Chemistry; EXT; Ext steroid pnl; Pan; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.75 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|
102078-3 |
Chimeric antigen receptor T-cell therapy panel |
- |
XXX |
Pt |
- |
|
|
ACTIVE |
CAR-T therapy panel - Specimen |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DRUG/TOX |
|
102078-3 |
|
|
|
|
Order |
|
|
|
0 |
CAR-T panel Spec |
|
|
|
N |
|
Ag; CAR-T panel; DRUG/TOXICOLOGY; Drugs; Misc; Miscellaneous; Other; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Spec; T cell; T prime; To be specified in another part of the message; UCHL-1; Unspecified |
2.75 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|
102082-5 |
Alpha-1-Antitrypsin Proteotype panel |
- |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Alpha-1-Antitrypsin Proteotype Panel - Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
102082-5 |
|
|
|
|
Order |
|
|
|
0 |
A1AT Proteotype panel SerPl |
|
|
|
N |
|
A1; A1A; A1AT; A-1-AT; A1-AT; A1AT Proteotype panel; AAT; Alfa; Alpha-1-antitrypsin.total; Alpha-1-protease inhibitor; Alpha-1-proteinase inhibitor; Alpha-1-trypsin inhibitor; Chemistry; i; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.76 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|
102083-3 |
Arginine Stimulation XXX Challenge Panel |
- |
Ser/Plas |
Pt |
- |
IA |
|
ACTIVE |
Arginine stimulation challenge panel - Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHAL |
|
102083-3 |
|
IA |
|
|
Order |
|
|
|
0 |
Arginine stim chal pnl SerPl IA |
|
|
|
N |
|
Arg; Arginine stim chal pnl; CHEMISTRY.CHALLENGE TESTING; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Stim; SUDS |
2.76 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|
102084-1 |
B-Cell lymphoblastic leukemia monitoring minimal residual disease detection |
- |
Bld/Bone mar |
Pt |
- |
Flow cytometry |
|
ACTIVE |
B-Cell lymphoblastic leukemia monitoring minimal residual disease detection in Blood or Marrow by Flow cytometry (FC) |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CELLMARK |
|
102084-1 |
|
Flow cytometry |
|
|
Order |
|
|
|
0 |
BCell Lym LK monitor MRD det Bld/Mar FC |
|
|
|
N |
|
B Cell; B-ALL; B-cell acute lymphoblastic leukemia; BCell Lym LK monitor MRD det; BCELLS; Bld/Mar; Blood; BM; BON; Bone marrow; CELL MARKERS; Dis; Diseases; Dynamic; Dz; FC; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Pan; Panel; PANEL.CELLMARK; Panl; Pnl; Point in time; Random; WB; Whole blood; Whole blood or Bone marrow |
2.75 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|
102085-8 |
CNS demyelinating disease panel |
- |
Ser/Plas |
Pt |
- |
Flow cytometry |
|
ACTIVE |
CNS Demyelinating Disease Panel - Serum or Plasma by Flow cytometry (FC) |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MOLPATH |
|
102085-8 |
|
Flow cytometry |
|
|
Order |
|
|
|
0 |
CNS Demyelinating ds Panel SerPl FC |
|
|
|
N |
|
CNS Demyelinating ds Panel; Dis; Diseases; Dynamic; Dz; FC; Molecular pathology; MOLPATH; Pan; Panel.molpath; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.75 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|
103217-6 |
Mean respiratory rate |
NRat |
Respiratory system |
XXX |
- |
|
|
ACTIVE |
Mean respiratory rate |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HRTRATE.ATOM |
|
103217-6 |
|
|
|
|
Observation |
|
|
|
0 |
Mean RR |
|
|
|
N |
|
?Tm; Average; Avg; Breathing; Count/time; Heart Rate; HEART RATE.ATOM; Lungs; Mean resp rate; nRate; Number rate; Number Rate = Count/Time; RS |
2.76 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
|
102087-4 |
Gastrin secretin stimulation XXX challenge panel |
- |
Ser |
Pt |
- |
|
|
ACTIVE |
Secretin stimulation/Gastrin XXX challenge panel |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHAL |
|
102087-4 |
|
|
|
|
Order |
|
|
|
0 |
Secretin stim/Gastrin chal pnl Ser |
|
|
|
N |
|
CHEMISTRY.CHALLENGE TESTING; Gastrin secretin stim XXX chal pnl; Pan; PANEL.CHALLENGE; Panl; Pnl; Point in time; Random; Secretin stim chal pnl; Serum; SR; Stim; Total gastrins; Zollinger-Ellison syndrome |
2.76 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|
102096-5 |
HLA-DQA1 SSO panel |
- |
Bld/Tiss |
Pt |
- |
Probe.amp.tar |
|
ACTIVE |
HLA-DQA1 SSO panel - Blood or Tissue by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HLA |
|
102096-5 |
|
Probe.amp.tar |
|
|
Order |
|
|
|
0 |
HLA-DQA1 SSO pnl Bld/T NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; HLA ANTIGEN; HLA-DQA1 SSO pnl; Human Leukocyte Antigen; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.HLA; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification; WB; Whole blood; Whole blood or Tissue |
2.75 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|
103139-2 |
Systemic lupus Ab panel |
- |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Systemic lupus Ab panel - Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SERO |
|
103139-2 |
|
|
|
|
Order |
|
|
|
0 |
SL Panel SerPl |
|
|
|
N |
|
Pan; PANEL.SEROLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SL Panel; SR |
2.75 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|
102102-1 |
Vitamin B3 & metabolites panel |
- |
Ser/Plas |
Pt |
- |
LC/MS/MS |
|
ACTIVE |
Vitamin B3 and metabolites panel - Serum or Plasma by LC/MS/MS |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
102102-1 |
|
LC/MS/MS |
|
|
Order |
|
|
|
0 |
Vit B3 + metabolites Pnl SerPl LC/MS/MS |
|
|
|
N |
|
Chemistry; Metabolite; Metb; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vit B3 + metabolites Pnl |
2.75 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|
102103-9 |
Acute myeloid leukemia panel |
- |
Bld/Tiss |
Pt |
- |
FISH |
|
ACTIVE |
Acute myeloid leukemia panel - Blood or Tissue by FISH |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MOLPATH |
|
102103-9 |
|
FISH |
|
|
Order |
|
|
|
0 |
AML panel Bld/T FISH |
|
|
|
N |
|
AML; AML panel; Blood; Fluorescent in situ hybridization; Molecular pathology; MOLPATH; Myelo; Pan; Panel.molpath; Panl; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.75 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|
103148-3 |
Steroid drug screening panel |
- |
Ser/Plas |
Pt |
- |
LC/MS/MS |
|
ACTIVE |
Steroid drug screening panel - Serum or Plasma by LC/MS/MS |
|
ADD |
DefinitionDescription |
|
|
|
|
|
12434-7 pr |
|
|
|
PANEL.DRUG/TOX |
|
103148-3 |
|
LC/MS/MS |
|
|
Order |
|
|
|
0 |
Steroid drug screen pnl SerPl LC/MS/MS |
|
|
|
N |
|
Asympt; Asymptomatic; DRUG/TOXICOLOGY; Drugs; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Scn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.75 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
|